Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
1996 1
1997 1
1998 2
1999 3
2000 5
2002 3
2003 4
2004 1
2005 4
2006 3
2007 1
2009 1
2010 3
2011 11
2012 8
2013 9
2014 3
2015 10
2016 7
2017 8
2018 7
2019 10
2020 6
2021 9
2022 2
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Results by year

Filters applied: . Clear all
Page 1
Response to Berlaimont and Welby.
Checchi M, Mesher D, Mohammed H, Soldan K. Checchi M, et al. Among authors: soldan k. Sex Transm Infect. 2019 Nov;95(7):553. doi: 10.1136/sextrans-2019-054148. Epub 2019 Jul 18. Sex Transm Infect. 2019. PMID: 31320395 No abstract available.
Developing role of HPV in cervical cancer prevention.
Kitchener HC, Denton K, Soldan K, Crosbie EJ. Kitchener HC, et al. Among authors: soldan k. BMJ. 2013 Aug 7;347:f4781. doi: 10.1136/bmj.f4781. BMJ. 2013. PMID: 23926316 Review. No abstract available.
Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study.
Zivanovic O, Chi DS, Zhou Q, Iasonos A, Konner JA, Makker V, Grisham RN, Brown AK, Nerenstone S, Diaz JP, Schroeder ED, Langstraat CL, Paroder V, Lakhman Y, Soldan K, Su K, Gardner GJ, Andikyan V, Guo J, Jewell EL, Long Roche K, Troso-Sandoval T, Lichtman SM, Moukarzel LA, Dessources K, Abu-Rustum NR, Aghajanian C, Tew WP, Beumer J, Sonoda Y, O'Cearbhaill RE. Zivanovic O, et al. Among authors: soldan k. J Clin Oncol. 2021 Aug 10;39(23):2594-2604. doi: 10.1200/JCO.21.00605. Epub 2021 May 21. J Clin Oncol. 2021. PMID: 34019431 Free PMC article. Clinical Trial.
Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes.
Mesher D, Soldan K, Lehtinen M, Beddows S, Brisson M, Brotherton JM, Chow EP, Cummings T, Drolet M, Fairley CK, Garland SM, Kahn JA, Kavanagh K, Markowitz L, Pollock KG, Söderlund-Strand A, Sonnenberg P, Tabrizi SN, Tanton C, Unger E, Thomas SL. Mesher D, et al. Among authors: soldan k. Emerg Infect Dis. 2016 Oct;22(10):1732-40. doi: 10.3201/eid2210.160675. Emerg Infect Dis. 2016. PMID: 27648688 Free PMC article. Review.
Morbidity after secondary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for ovarian cancer: An analysis of a randomized phase II trial.
Praiss AM, Zhou Q, Iasonos A, Moukarzel L, Dessources K, Soldan K, Su K, Sonoda Y, Roche KL, Gardner GJ, Troso-Sandoval T, Tew WP, Grisham RN, Chi DS, O'Cearbhaill RE, Zivanovic O. Praiss AM, et al. Among authors: soldan k. Gynecol Oncol. 2023 Apr;171:23-30. doi: 10.1016/j.ygyno.2023.02.003. Epub 2023 Feb 16. Gynecol Oncol. 2023. PMID: 36804618 Free PMC article. Clinical Trial.
Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study.
Rubinstein MM, Doria ER, Konner J, Lichtman S, Zhou Q, Iasonos A, Sarasohn D, Troso-Sandoval T, Friedman C, O'Cearbhaill R, Cadoo K, Kyi C, Cohen S, Soldan K, Billinson E, Caird I, Jang D, Eid K, Shah P, Guillen J, Aghajanian C, Zamarin D, Makker V. Rubinstein MM, et al. Among authors: soldan k. Gynecol Oncol. 2023 Feb;169:64-69. doi: 10.1016/j.ygyno.2022.11.028. Epub 2022 Dec 10. Gynecol Oncol. 2023. PMID: 36512912 Free PMC article. Clinical Trial.
Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third Remission.
Manning-Geist BL, Gnjatic S, Aghajanian C, Konner J, Kim SH, Sarasohn D, Soldan K, Tew WP, Sarlis NJ, Zamarin D, Kravetz S, Laface I, Rasalan-Ho T, Qi J, Wong P, Sabbatini PJ, O'Cearbhaill RE. Manning-Geist BL, et al. Among authors: soldan k. Cancers (Basel). 2023 Feb 25;15(5):1458. doi: 10.3390/cancers15051458. Cancers (Basel). 2023. PMID: 36900251 Free PMC article.
111 results